Evidence map›Paper›PMID 37866921›Full record

ArticleInternal medicine (Tokyo, Japan)2024

Hereditary Hemorrhagic Telangiectasia in a Patient Undergoing Hemodialysis with Anticoagulants and Antiplatelets.

Emiko Otsuka, Mineaki Kitamura, Kenji Sawase, Maiko Nakamura, Hiro Inoue, Kosei Yamaguchi, Satoshi Funakoshi, Takahiro Takazono, Hiroshi Mukae, Tomoya Nishino

Open access · diamondAbstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Internal medicine (Tokyo, Japan), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.3field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 1 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Emiko OtsukaDepartment of Nephrology, Nagasaki University Graduate School of Biomedical Sciences, Japan.
Mineaki KitamuraDepartment of Nephrology, Nagasaki University Graduate School of Biomedical Sciences, Japan.
Kenji SawaseNagasaki Renal Center, Japan.
Maiko NakamuraDepartment of Nephrology, Nagasaki University Graduate School of Biomedical Sciences, Japan.
Hiro InoueDepartment of Nephrology, Nagasaki University Graduate School of Biomedical Sciences, Japan.
Kosei YamaguchiDepartment of Nephrology, Nagasaki University Graduate School of Biomedical Sciences, Japan.
Satoshi FunakoshiNagasaki Renal Center, Japan.
Takahiro TakazonoDepartment of Respiratory Medicine, Nagasaki University Graduate School of Biomedical Sciences, Japan.
Hiroshi MukaeDepartment of Respiratory Medicine, Nagasaki University Graduate School of Biomedical Sciences, Japan.
Tomoya NishinoDepartment of Nephrology, Nagasaki University Graduate School of Biomedical Sciences, Japan.
Nagasaki Medical Center · JPNagasaki University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Hereditary hemorrhagic telangiectasia (HHT) is an autosomal dominant disorder that causes abnormal blood vessel formation and bleeding. We herein report a 61-year-old woman with aggravated HHT symptoms after hemodialysis initiation. She was diagnosed with HHT based on her recurrent bleeding, abnormal blood vessel formation, and family history. Despite bleeding complications, the patient required anticoagulants and antiplatelet agents to treat cardiovascular complications. Eventually, the patient died of extensive cerebral hemorrhaging. Our experience suggests that special attention should be paid to bleeding complications in high-risk patients.

Indexed as

AnticoagulantsPlatelet Aggregation InhibitorsRenal DialysisTelangiectasia, Hereditary HemorrhagicFatal OutcomeFemaleHumansMiddle AgedAnticoagulantsPlatelet Aggregation Inhibitorshemodialysishereditary hemorrhagic telangiectasiaOsler-Weber-Rendu diseasepulmonary arteriovenous fistula

Identifiers

PMID37866921
PMCPMC11189710
OpenAlexW4387795914

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.